1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Oncology CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Preclinical Oncology CRO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Oncology CRO Market Perspective (2016-2027)
2.2 Preclinical Oncology CRO Growth Trends by Regions
2.2.1 Preclinical Oncology CRO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preclinical Oncology CRO Historic Market Share by Regions (2016-2021)
2.2.3 Preclinical Oncology CRO Forecasted Market Size by Regions (2022-2027)
2.3 Preclinical Oncology CRO Industry Dynamic
2.3.1 Preclinical Oncology CRO Market Trends
2.3.2 Preclinical Oncology CRO Market Drivers
2.3.3 Preclinical Oncology CRO Market Challenges
2.3.4 Preclinical Oncology CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Oncology CRO Players by Revenue
3.1.1 Global Top Preclinical Oncology CRO Players by Revenue (2016-2021)
3.1.2 Global Preclinical Oncology CRO Revenue Market Share by Players (2016-2021)
3.2 Global Preclinical Oncology CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preclinical Oncology CRO Revenue
3.4 Global Preclinical Oncology CRO Market Concentration Ratio
3.4.1 Global Preclinical Oncology CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Oncology CRO Revenue in 2020
3.5 Preclinical Oncology CRO Key Players Head office and Area Served
3.6 Key Players Preclinical Oncology CRO Product Solution and Service
3.7 Date of Enter into Preclinical Oncology CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Oncology CRO Breakdown Data by Type
4.1 Global Preclinical Oncology CRO Historic Market Size by Type (2016-2021)
4.2 Global Preclinical Oncology CRO Forecasted Market Size by Type (2022-2027)
5 Preclinical Oncology CRO Breakdown Data by Application
5.1 Global Preclinical Oncology CRO Historic Market Size by Application (2016-2021)
5.2 Global Preclinical Oncology CRO Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Preclinical Oncology CRO Market Size (2016-2027)
6.2 North America Preclinical Oncology CRO Market Size by Type
6.2.1 North America Preclinical Oncology CRO Market Size by Type (2016-2021)
6.2.2 North America Preclinical Oncology CRO Market Size by Type (2022-2027)
6.2.3 North America Preclinical Oncology CRO Market Size by Type (2016-2027)
6.3 North America Preclinical Oncology CRO Market Size by Application
6.3.1 North America Preclinical Oncology CRO Market Size by Application (2016-2021)
6.3.2 North America Preclinical Oncology CRO Market Size by Application (2022-2027)
6.3.3 North America Preclinical Oncology CRO Market Size by Application (2016-2027)
6.4 North America Preclinical Oncology CRO Market Size by Country
6.4.1 North America Preclinical Oncology CRO Market Size by Country (2016-2021)
6.4.2 North America Preclinical Oncology CRO Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Preclinical Oncology CRO Market Size (2016-2027)
7.2 Europe Preclinical Oncology CRO Market Size by Type
7.2.1 Europe Preclinical Oncology CRO Market Size by Type (2016-2021)
7.2.2 Europe Preclinical Oncology CRO Market Size by Type (2022-2027)
7.2.3 Europe Preclinical Oncology CRO Market Size by Type (2016-2027)
7.3 Europe Preclinical Oncology CRO Market Size by Application
7.3.1 Europe Preclinical Oncology CRO Market Size by Application (2016-2021)
7.3.2 Europe Preclinical Oncology CRO Market Size by Application (2022-2027)
7.3.3 Europe Preclinical Oncology CRO Market Size by Application (2016-2027)
7.4 Europe Preclinical Oncology CRO Market Size by Country
7.4.1 Europe Preclinical Oncology CRO Market Size by Country (2016-2021)
7.4.2 Europe Preclinical Oncology CRO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Oncology CRO Market Size (2016-2027)
8.2 Asia-Pacific Preclinical Oncology CRO Market Size by Type
8.2.1 Asia-Pacific Preclinical Oncology CRO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preclinical Oncology CRO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preclinical Oncology CRO Market Size by Type (2016-2027)
8.3 Asia-Pacific Preclinical Oncology CRO Market Size by Application
8.3.1 Asia-Pacific Preclinical Oncology CRO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preclinical Oncology CRO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preclinical Oncology CRO Market Size by Application (2016-2027)
8.4 Asia-Pacific Preclinical Oncology CRO Market Size by Region
8.4.1 Asia-Pacific Preclinical Oncology CRO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preclinical Oncology CRO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Preclinical Oncology CRO Market Size (2016-2027)
9.2 Latin America Preclinical Oncology CRO Market Size by Type
9.2.1 Latin America Preclinical Oncology CRO Market Size by Type (2016-2021)
9.2.2 Latin America Preclinical Oncology CRO Market Size by Type (2022-2027)
9.2.3 Latin America Preclinical Oncology CRO Market Size by Type (2016-2027)
9.3 Latin America Preclinical Oncology CRO Market Size by Application
9.3.1 Latin America Preclinical Oncology CRO Market Size by Application (2016-2021)
9.3.2 Latin America Preclinical Oncology CRO Market Size by Application (2022-2027)
9.3.3 Latin America Preclinical Oncology CRO Market Size by Application (2016-2027)
9.4 Latin America Preclinical Oncology CRO Market Size by Country
9.4.1 Latin America Preclinical Oncology CRO Market Size by Country (2016-2021)
9.4.2 Latin America Preclinical Oncology CRO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Oncology CRO Market Size (2016-2027)
10.2 Middle East & Africa Preclinical Oncology CRO Market Size by Type
10.2.1 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2016-2027)
10.3 Middle East & Africa Preclinical Oncology CRO Market Size by Application
10.3.1 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2016-2027)
10.4 Middle East & Africa Preclinical Oncology CRO Market Size by Country
10.4.1 Middle East & Africa Preclinical Oncology CRO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preclinical Oncology CRO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Preclinical Oncology CRO Introduction
11.1.4 Crown Bioscience Revenue in Preclinical Oncology CRO Business (2016-2021)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Preclinical Oncology CRO Introduction
11.2.4 Charles River Laboratory Revenue in Preclinical Oncology CRO Business (2016-2021)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc.
11.3.1 ICON Plc. Company Details
11.3.2 ICON Plc. Business Overview
11.3.3 ICON Plc. Preclinical Oncology CRO Introduction
11.3.4 ICON Plc. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.3.5 ICON Plc. Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical Oncology CRO Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical Oncology CRO Business (2016-2021)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Preclinical Oncology CRO Introduction
11.5.4 Taconic Biosciences Revenue in Preclinical Oncology CRO Business (2016-2021)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Preclinical Oncology CRO Introduction
11.6.4 Covance Revenue in Preclinical Oncology CRO Business (2016-2021)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Preclinical Oncology CRO Introduction
11.7.4 EVOTEC Revenue in Preclinical Oncology CRO Business (2016-2021)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Preclinical Oncology CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Preclinical Oncology CRO Business (2016-2021)
11.8.5 The Jackson Laboratory Recent Development
11.9 Wuxi AppTec.
11.9.1 Wuxi AppTec. Company Details
11.9.2 Wuxi AppTec. Business Overview
11.9.3 Wuxi AppTec. Preclinical Oncology CRO Introduction
11.9.4 Wuxi AppTec. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.9.5 Wuxi AppTec. Recent Development
11.10 MI Bioresearch, Inc.
11.10.1 MI Bioresearch, Inc. Company Details
11.10.2 MI Bioresearch, Inc. Business Overview
11.10.3 MI Bioresearch, Inc. Preclinical Oncology CRO Introduction
11.10.4 MI Bioresearch, Inc. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.10.5 MI Bioresearch, Inc. Recent Development
11.11 Champion Oncology, Inc.
11.11.1 Champion Oncology, Inc. Company Details
11.11.2 Champion Oncology, Inc. Business Overview
11.11.3 Champion Oncology, Inc. Preclinical Oncology CRO Introduction
11.11.4 Champion Oncology, Inc. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.11.5 Champion Oncology, Inc. Recent Development
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Preclinical Oncology CRO Introduction
11.12.4 Xentech Revenue in Preclinical Oncology CRO Business (2016-2021)
11.12.5 Xentech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
【免責事項】
https://www.globalresearch.jp/disclaimer